To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4107 | Pf-7006 |
Highly selective, extremely potent Mps1 kinase inhibitor
More description
|
|
| DCC4106 | Pf-68742 |
Novel Entry Inhibitor of both CCR5- and CXCR4-Tropic Strains of Human Immunodeficiency Virus Type 1 (HIV-1), Targeting a Novel Site on gp41
More description
|
|
| DCC4105 | Pf-562771 |
Novel potent and selective inhibitor of the activation-loop mutant Kit phosphorylation and tumor growth
More description
|
|
| DCC4104 | Pf-562271 Tosylate |
Potent, ATP-competitive, reversible inhibitor of FAK
More description
|
|
| DCC4103 | pf-5466 |
Antimalarial, actively against Plasmodium liver stages
More description
|
|
| DCC4101 | Pf-5177624 |
Selective and potent PDK1 inhibitor inducing anti-tumor activity in breast cancer cells
More description
|
|
| DCC4100 | Pf-4522654 |
Potent and selective 5-HT2C receptor agonist
More description
|
|
| DCC4099 | Pf-3837 |
Highly selective, extremely potent Mps1 kinase inhibitor
More description
|
|
| DCC4098 | Pf-3604861 |
Novel dual H3/4 histamine receptor antagonist
More description
|
|
| DCC4097 | Pf-184563 |
Potent, selective non-peptidic antagonist of the V1a receptor
More description
|
|
| DCC4096 | Pf1070a |
Natural cyclic tetrapeptide HDAC Inhibitor through the inhibition of PfHDAC1 catalytic activity, potently inducing the synthesis of metallothionein
More description
|
|
| DCC4095 | Pf-06939999 |
Novel SAM Competitive PRMT5 Inhibitor, Demonstrating Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance
More description
|
|
| DCC4094 | Pf-06843195 Prodrug |
Novel prdrug of PF-06843195, a potent PI3Kα-selective inhibitor
More description
|
|
| DCC4092 | Pf-06758955 Hydrochloride |
Novel potent and selective inhibitor of MAP4K4
More description
|
|
| DCC4091 | Pf-06756394 |
Novel tyrosine residues probe, rationally targeting active site
More description
|
|
| DCC4090 | Pf-06745013 |
Novel potent and selective inhibitor of MAP4K4
More description
|
|
| DCC4089 | Pf-06655075 |
Novel non-brain-penetrant long-acting peptide oxytocin (OT) receptor agonist with increased selectivity for the OT receptor and significantly increased pharmacokinetic stability
More description
|
|
| DCC4087 | Pf-06371900 |
Novel potent and highly selective leucine rich repeat kinase 2 (LRRK2) inhibitor
More description
|
|
| DCC4086 | Pf-05214030 |
Novel potent TRPV4 antagonist (hTRPV4 IC50 4nM; rTRPV4 IC50 27nM)
More description
|
|
| DCC4085 | Pf-05109794 |
Novel selective hTRPV4 Antagonist (hTRPV4 IC50 49nM; rTRPV4 IC50 1,150nM)
More description
|
|
| DCC4084 | pf-04859989 |
Irriversible inhibitor of kynurenine amino transferase II (KAT II)
More description
|
|
| DCC4083 | Pf-04671536 Hydrochloride |
Novel potent and selective PDE8B/8A inhibitor
More description
|
|
| DCC4082 | Pf-04363467 Hydrochloride |
Selective dopamine D3/D2 receptor antagonist
More description
|
|
| DCC4081 | Pf-03671148 |
Dose dependent inhibitor of multiple fibrotic genes
More description
|
|
| DCC4080 | Pf-03084014 |
Novel γ-secretase inhibitor
More description
|
|
| DCC4078 | Pet-16 |
Novel allosteric inhibitor of E. coli Hsp70 (DnaK) and human Hsp70 proteins
More description
|
|
| DCC4077 | Perindopril |
Non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor
More description
|
|
| DCC4076 | Peridinin |
Exceptionally Potent and Membrane-Embedded Inhibitor of Bilayer Lipid Peroxidation
More description
|
|
| DCC4075 | Pergolide Mesylate |
Agonist of dopamine receptor subtypes D1 and D2
More description
|
|
| DCC4074 | Peptide P9r |
Broad-spectrum virus- and host-targeting peptide, inhibiting coronaviruses and other respiratory viruses
More description
|
|